NCI COVID-19 in Cancer Patients, NCCAPS Study
Inclusion Criteria
- STEP 0 ELIGIBILITY CRITERIA:
- Patient must have a prior or current cancer diagnosis (e.g., solid tumor or hematologic malignancy) that fits into any one of the following categories: * Patient is receiving active treatment (defined as current treatment or treatment within the past 6 weeks) or will begin receiving treatment within the next 2 weeks for any central nervous system (CNS) or hematologic malignancy or metastatic (stage IV) solid tumor. Eligible treatment types for hematologic malignancy or metastatic cancer are chemotherapy, immunotherapy, monoclonal antibody therapy (e.g., rituximab, trastuzumab, cetuximab), targeted therapy (e.g., BRAF/MEK inhibitor, EGF-R inhibitor), endocrine therapy, radiation therapy, or targeted radionuclide therapy; or * Patient is receiving treatment (defined as current treatment or treatment within the past 6 weeks) or will begin receiving treatment within the next 2 weeks for non-metastatic (stage I-III) solid tumor. Eligible treatment types for non-metastatic cancer patients are intravenous chemotherapy, immunotherapy, targeted therapy, radiation therapy, targeted radionuclide therapy, or monoclonal antibody therapy, except trastuzumab/pertuzumab if not accompanied by chemotherapy; or * Patient has received an allogenic stem cell transplant or chimeric antigen receptor (CAR)-T cell or other modified cellular therapy at any time; or * Patient is currently receiving treatment or prophylaxis for graft versus (vs.) host disease; or * Patient has received an autologous bone marrow transplant within the past 2 years.
- Patient must have a pending or known positive viral test result for SARS-CoV-2. Patients with prior negative viral SARS CoV-2 test(s) are eligible if they are being tested again. Patients 18 years of age and older with prior positive viral SARS CoV-2 test(s) more than 14 days prior to enrollment to Step 1 are not eligible
- Human immunodeficiency virus (HIV)-infected patients are eligible
- Patients with CNS metastases are eligible
- Co-enrollment on other clinical trials (for cancer or for COVID-19) is allowed
- STEP 1 ELIGIBILITY CRITERIA: Positive viral SARS CoV-2 test * Patient must have a documented positive viral SARS CoV-2 test ** For patients 18 years of age or older, the specimen collection for the positive test must have occurred no earlier than 14 days prior to enrollment to Step 1 ** For patients under 18 years of age, the specimen collection for the positive test must have occurred after January 31, 2020 * The viral test can be either a nucleic acid (PCR) test or an antigen test. Serological or antibody tests are not allowed. The test must have received Emergency Use Approval (EUA) from the Food and Drug Administration (FDA) and be performed in a Clinical Laboratory Improvement Act (CLIA) certified lab or patient care setting operating under a CLIA Certificate of Waiver. A full list of tests that have been approved under the EUA can be accessed at: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas Any specimen source (e.g., nasopharyngeal swab, oropharyngeal swab, etc.) is allowable for the viral SARS-CoV-2 test.
Alabama
Birmingham
Mobile
Alaska
Anchorage
Fairbanks
Arizona
Kingman
Mesa
Phoenix
Scottsdale
Arkansas
Ft. Smith
Hot Springs
Jonesboro
Little Rock
California
Anaheim
Antioch
Arroyo Grande
Baldwin Park
Bellflower
Burbank
Chico
Costa Mesa
Dublin
Fontana
Fremont
Fresno
Harbor City
Irvine
La Jolla
Loma Linda
Los Angeles
Modesto
Oakland
Ontario
Orange
Panorama City
Rancho Cordova
Redwood City
Richmond
Riverside
Rohnert Park
Roseville
Sacramento
Salinas
San Diego
San Francisco
San Jose
San Leandro
San Marcos
San Rafael
Santa Clara
Santa Maria
Santa Rosa
South San Francisco
Stockton
Truckee
Vacaville
Vallejo
Walnut Creek
Woodland Hills
Colorado
Aurora
Boulder
Centennial
Colorado Springs
Denver
Durango
Englewood
Golden
Grand Junction
Greeley
Lafayette
Lakewood
Littleton
Lone Tree
Longmont
Loveland
Parker
Pueblo
Thornton
Wheat Ridge
Connecticut
West Haven
Delaware
Frankford
Lewes
Newark
Rehoboth Beach
Seaford
Wilmington
District of Columbia
Washington
Florida
Aventura
Bradenton
Deerfield Beach
Fort Lauderdale
Gainesville
Miami Beach
Sarasota
Tampa
Venice
Georgia
Albany
Athens
Augusta
Braselton
Decatur
Gainesville
Savannah
Hawaii
Honolulu
Idaho
Boise
Caldwell
Coeur D'Alene
Emmett
Fruitland
Meridian
Nampa
Post Falls
Sandpoint
Twin Falls
Illinois
Aurora
Bloomington
Canton
Carbondale
Carterville
Carthage
Centralia
Chicago
Danville
Decatur
Dixon
Effingham
Eureka
Galesburg
Harvey
Hines
Kewanee
Macomb
Mattoon
Mount Vernon
New Lenox
O'Fallon
Orland Park
Ottawa
Park Ridge
Pekin
Peoria
Peru
Princeton
River Forest
Springfield
Swansea
Urbana
Yorkville
Indiana
Carmel
Goshen
Indianapolis
Richmond
South Bend
Iowa
Cedar Rapids
Clive
Council Bluffs
Creston
Des Moines
Fort Dodge
West Des Moines
Kansas
Fairway
Hays
Kansas City
Lawrence
Olathe
Overland Park
Pittsburg
Salina
Topeka
Westwood
Kentucky
Bardstown
Corbin
Lexington
London
Louisville
Shepherdsville
Louisiana
Baton Rouge
Covington
Houma
Kenner
Metairie
Monroe
New Orleans
Shreveport
Maine
Augusta
Bangor
Belfast
Biddeford
Brewer
Portland
Rockport
Sanford
Scarborough
South Portland
Maryland
Baltimore
Frederick
Kensington
Massachusetts
Beverly
Boston
Burlington
Gloucester
Lowell
Springfield
Winchester
Michigan
Ann Arbor
Battle Creek
Bay City
Brighton
Brownstown
Canton
Caro
Chelsea
Clarkston
Clinton Township
Dearborn
Detroit
East China
East Lansing
Farmington Hills
Flint
Grand Rapids
Grosse Pointe Woods
Jackson
Kalamazoo
Lansing
Livonia
Macomb Township
Marlette
Midland
Mount Clemens
Mount Pleasant
Muskegon
Niles
Norton Shores
Novi
Petoskey
Pontiac
Port Huron
Reed City
Rochester Hills
Royal Oak
Saginaw
Saint Joseph
Shelby Township
Southfield
Sterling Heights
Tawas City
Traverse City
Troy
Warren
West Bloomfield
West Branch
Wyoming
Ypsilanti
Minnesota
Bemidji
Burnsville
Cambridge
Coon Rapids
Edina
Fridley
Mankato
Maple Grove
Maplewood
Minneapolis
Monticello
New Ulm
Princeton
Robbinsdale
Rochester
Saint Cloud
Saint Louis Park
Saint Paul
Shakopee
Stillwater
Waconia
Willmar
Woodbury
Wyoming
Mississippi
Columbus
Grenada
Gulfport
Jackson
New Albany
Oxford
Southhaven
Missouri
Ballwin
Branson
Cape Girardeau
Columbia
Farmington
Jefferson City
Joplin
Kansas City
Lee's Summit
North Kansas City
Rolla
Saint Joseph
Saint Louis
Sainte Genevieve
Springfield
Sullivan
Sunset Hills
Washington
Montana
Anaconda
Billings
Bozeman
Butte
Great Falls
Kalispell
Missoula
Nebraska
Bellevue
Grand Island
Kearney
Lincoln
Omaha
Papillion
Nevada
Carson City
Henderson
Las Vegas
Pahrump
Reno
New Hampshire
Dover
Lebanon
Nashua
New Jersey
Camden
Elizabeth
Flemington
Livingston
Long Branch
Morristown
Mullica Hill
New Brunswick
Newark
Newton
Sewell
Somerville
Summit
Teaneck
Toms River
Vineland
Voorhees
New Mexico
Albuquerque
New York
Auburn
Bronx
East Syracuse
New York
Rochester
Stony Brook
Syracuse
North Carolina
Chapel Hill
Durham
Gastonia
Greenville
Hendersonville
Kenansville
Kinston
New Bern
Richlands
Rocky Mount
Washington
North Dakota
Bismarck
Fargo
Minot
Ohio
Akron
Beavercreek
Belpre
Boardman
Centerville
Chillicothe
Cincinnati
Cleveland
Columbus
Dayton
Delaware
Dublin
Findlay
Franklin
Gahanna
Greenville
Grove City
Kettering
Lancaster
Mansfield
Marietta
Marion
Mount Vernon
Newark
Portsmouth
Springfield
Toledo
Troy
Warren
West Chester
Westerville
Youngstown
Zanesville
Oklahoma
Oklahoma City
Oregon
Baker City
Bend
Clackamas
Coos Bay
Newberg
Ontario
Portland
Redmond
Pennsylvania
Allentown
Bethlehem
Bryn Mawr
Chadds Ford
Danville
Doylestown
Dunmore
East Stroudsburg
Ephrata
Erie
Gettysburg
Hanover
Hazleton
Hershey
Jefferson Hills
Lebanon
Lewisburg
Lewistown
Meadowbrook
Media
Monroeville
Natrona Heights
Paoli
Philadelphia
Pittsburgh
Pottstown
Pottsville
Scranton
Selinsgrove
State College
Wexford
Wilkes-Barre
Willow Grove
Wynnewood
York
Puerto Rico
San Juan
Rhode Island
Providence
South Carolina
Anderson
Boiling Springs
Charleston
Columbia
Easley
Gaffney
Greenville
Greenwood
Greer
Hilton Head Island
Seneca
Spartanburg
Union
South Dakota
Sioux Falls
Tennessee
Collierville
Knoxville
Lenoir City
Maryville
Memphis
Nashville
Oak Ridge
Texas
Austin
Beaumont
Bryan
Dallas
Fort Worth
Houston
Lubbock
Port Arthur
Richardson
San Antonio
Utah
Farmington
Salt Lake City
Vermont
Saint Johnsbury
Virginia
Fishersville
McLean
Mechanicsville
Midlothian
Richmond
Winchester
Washington
Aberdeen
Bellevue
Bellingham
Bremerton
Burien
Centralia
Edmonds
Enumclaw
Everett
Federal Way
Issaquah
Kennewick
Lacey
Lakewood
Longview
Port Townsend
Poulsbo
Renton
Seattle
Sedro-Woolley
Shelton
Spokane
Tacoma
Vancouver
Walla Walla
Yelm
West Virginia
Charleston
Princeton
Wisconsin
Antigo
Appleton
Brookfield
Burlington
Chilton
Chippewa Falls
Eau Claire
Franklin
Germantown
Grafton
Green Bay
Kenosha
La Crosse
Ladysmith
Madison
Marinette
Marshfield
Medford
Mequon
Milwaukee
Minocqua
New Richmond
Oconto Falls
Oshkosh
Racine
Rice Lake
Sheboygan
Stevens Point
Sturgeon Bay
Summit
Two Rivers
Wausau
Wauwatosa
Weston
Wisconsin Rapids
Wyoming
Cheyenne
Cody
Sheridan
Quebec
Greenfield Park
PRIMARY OBJECTIVES:
I. Characterize patient factors, such as pre-existing comorbidities, cancer type and treatment, and demographic factors, associated with short- and long-term outcomes of coronavirus 2 (COVID-19), including symptoms, severity, and fatality, in adult and pediatric cancer patients undergoing treatment.
II. Describe cancer treatment modifications made in response to COVID-19 in adult and pediatric patients, including dose adjustments, changes in symptom management, or temporary or permanent cessation.
III. Evaluate the association of COVID-19 with cancer outcomes in adult patient subgroups defined by clinico-pathologic characteristics and in pediatric patients.
CORRELATIVE OBJECTIVES:
I. Future correlative biomarker objectives will include assessment of the development of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS CoV-2) antibodies, description of the trajectory of cytokine abnormalities, description of coagulopathies, and genome-wide association studies to define polymorphisms associated with severe COVID-19.
II. Collection and banking of research blood specimens and radiological images for future research.
PATIENT-REPORTED HEALTH-RELATED QUALITY OF LIFE OBJECTIVES:
I. Describe patient-reported short-and long-term physical health, defined as a composite of physical function, pain interference and intensity, and ability to participate in social roles and activities, as measured by the Patient Reported Outcomes Measurement Information System (PROMIS)-29 version (v)2.0 profile in adult cancer patients diagnosed with COVID-19. (Primary)
II. Describe patient-reported short-and long-term symptoms (anxiety, depression, and dyspnea) and function (cognitive function and social isolation) in adult cancer patients diagnosed with COVID-19. (Secondary)
III. Assess how patient-reported physical health (primary objective) and symptoms and function (secondary objective) in adult cancer patients vary by COVID-19 symptom burden, cancer type, cancer treatment, comorbidities, tobacco use, body mass index, and demographic characteristics. (Exploratory)
OUTLINE:
Patients undergo collection of medical information about COVID-19 symptoms, treatments/cancer treatments and outcomes, and results from laboratory tests and imaging scans performed as part of routine care for up to 2 years. Patients also undergo collection of blood samples at the same times they receive routine bloodwork up to 9 times for adults and up to 6 times for children. Patients who are hospitalized for COVID-19 undergo collection of blood samples at up to 6 additional times for adults and up to 3 additional times for children. Adult patients also complete quality of life questionnaire.
Trial Phase Phase NA
Trial Type Registry
Lead Organization
National Cancer Institute
Principal Investigator
Larissa A. Korde
- Primary ID NCICOVID
- Secondary IDs NCI-2020-02986
- Clinicaltrials.gov ID NCT04387656